NCT06484192View on ClinicalTrials.gov

Pain Control After Lumbar Spine Fusion

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

428

Participants

Timeline

Start Date

June 28, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Spine FusionNSAID (Non-Steroidal Anti-Inflammatory Drug)Postoperative Pain
Interventions
DRUG

Naproxen 500 Mg

participants will receive Naproxen (500 mg) to take for 7 days after surgery as needed

DRUG

Ketorolac

participants will receive Ketorolac (15 mg) immediately after surgery

DRUG

OxyCODONE 5 mg Oral Tablet

participants will receive OxyCODONE (5 mg) to take for 7 days after surgery as needed

DRUG

Metaxalone 800 MG

participants will receive Metaxalone (800 MG) to take for 7 days after surgery as needed

Trial Locations (1)

19107

Rothman Orthopaedic Institute, Philadelphia

All Listed Sponsors
lead

Rothman Institute Orthopaedics

OTHER